AKM GLICLAZIDE gliclazide 60 mg modified release tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

gliclazide, Quantity: 60 mg

Disponible desde:

Pharmacor Pty Ltd

formulario farmacéutico:

Tablet, modified release

Composición:

Excipient Ingredients: lactose monohydrate; silicon dioxide; sodium acetate; magnesium stearate; mannitol; hypromellose

Vía de administración:

Oral

Unidades en paquete:

100's, 20's, 60's, 30's, 10's

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Resumen del producto:

Visual Identification: White to off-white, oblong shaped tablets, scored with a break bar on both sides, engraved with GL on one face and plain on the other face.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Registered

Fecha de autorización:

2020-04-29

Información para el usuario

_ _
_AKM GLICLAZIDE _
_Ver 00 1 _
_ _
_ _
AKM GLICLAZIDE TABLETS
The full CMI on the next page has more details. If you are worried
about using this medicine, speak to your doctor or pharmacist.
AKM GLICLAZIDE contains the active ingredient gliclazide.
AKM GLICLAZIDE is used so control blood glucose (sugar) in patients
with Type II diabetes mellitus. For more information, see
Section 1. Why am I using AKM GLICLAZIDE? in the full CMI.
Do not use if you have ever had an allergic reaction to AKM
GLICLAZIDE, macrolide antibiotics, or any of the ingredients listed at
the end of
the CMI.
TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY
OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME PREGNANT
OR ARE BREASTFEEDING.
For more information, see Section 2. What should I know before I use
AKM GLICLAZIDE ? in the full CMI.
Some medicines may interfere with AKM GLICLAZIDE and affect how it
works.
Tell your doctor, pharmacist or diabetes educator if you are taking
any other medicines, including medicines you buy without a
prescription
from a pharmacy, supermarket or health food shop.
See Section 3. What if I am taking other medicines? in the full CMI
for information.
Your doctor will tell you how many tablets to take each day. They may
increase or decrease the dose, depending on your blood glucose
levels.
More instructions can be found in Section 4. How do I use AKM
GLICLAZIDE? in the full CMI.
Tell all doctors, dentists, pharmacists and diabetes educators who are
involved with your treatment that you are taking AKM GLICLAZIDE.
If you are about to start taking any new medicines, tell you doctor
and pharmacist that you are taking.
For more information, see Section 5. What should I know while using
AKM GLICLAZIDE? in the full CMI.
There are a number of side effects associated with this medicine. It
is important to be aware of them so that you can identify any symptoms
if
they occur (see the full CMI for more details). The serious side
effects are:
Back pain, arthralgia, arthrosis, • high blood pressure, c